| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000233654.1 |
Tanespimycin |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009687183 |
Resistant |
| ENSG00000233654.1 |
Tanespimycin |
Chronic Lymphocytic Leukemia |
0.015323515 |
Resistant |
| ENSG00000233654.1 |
Tanespimycin |
Kidney renal clear cell carcinoma |
0.002248814 |
Sensitive |
